Undisclosed antiretroviral drug use in Botswana: implication for national estimates.

Sikhulile Moyo,Simani Gaseitsiwe,Kathleen M Powis,Molly Pretorius Holme,Terence Mohammed,Melissa Zahralban-Steele,Etienne K Yankinde,Comfort Maphorisa,William Abrams,Refeletswe Lebelonyane,Kutlo Manyake,Tumalano Sekoto,Mompati Mmalane,Tendani Gaolathe,Kathleen E Wirth,Joseph Makhema,Shahin Lockman,William Clarke, Max Essex,Vlad Novitsky

AIDS（2018）

引用 8|浏览34

暂无评分

摘要

Among 3596 HIV-positive participants enrolled in the Botswana Combination Prevention Project who self-reported no prior antiretroviral (ARV) therapy use andwere tested for viral load (nU951; 27% of all participants), 136 (14%) had HIV-1 RNA less than 400 copies/ml. ARV drugs were detected in 52 (39%) of 134 participants tested. Adjusting for undisclosed ARV use increased the overall estimate of virally suppressed individuals on ARV therapy by 1.4% from 70.2 to 71.6%.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要